111 related articles for article (PubMed ID: 16279779)
1. Some insights into the stereochemistry of inhibition of macrophage migration inhibitory factor with 2-fluoro-p-hydroxycinnamate and its analogues from molecular dynamics simulations.
Zhuang S; Zou J; Jiang Y; Mao X; Zhang B; Liu H; Yu Q
J Med Chem; 2005 Nov; 48(23):7208-14. PubMed ID: 16279779
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition.
Taylor AB; Johnson WH; Czerwinski RM; Li HS; Hackert ML; Whitman CP
Biochemistry; 1999 Jun; 38(23):7444-52. PubMed ID: 10360941
[TBL] [Abstract][Full Text] [Related]
3. Pro-1 of macrophage migration inhibitory factor functions as a catalytic base in the phenylpyruvate tautomerase activity.
Lubetsky JB; Swope M; Dealwis C; Blake P; Lolis E
Biochemistry; 1999 Jun; 38(22):7346-54. PubMed ID: 10353846
[TBL] [Abstract][Full Text] [Related]
4. Ionization state and molecular docking studies for the macrophage migration inhibitory factor: the role of lysine 32 in the catalytic mechanism.
Soares T; Goodsell D; Ferreira R; Olson AJ; Briggs JM
J Mol Recognit; 2000; 13(3):146-56. PubMed ID: 10867710
[TBL] [Abstract][Full Text] [Related]
5. Fragment screening of inhibitors for MIF tautomerase reveals a cryptic surface binding site.
McLean LR; Zhang Y; Li H; Choi YM; Han Z; Vaz RJ; Li Y
Bioorg Med Chem Lett; 2010 Mar; 20(6):1821-4. PubMed ID: 20185308
[TBL] [Abstract][Full Text] [Related]
6. Internal dynamics and ionization states of the macrophage migration inhibitory factor: comparison between wild-type and mutant forms.
Soares TA; Lins RD; Straatsma TP; Briggs JM
Biopolymers; 2002 Nov; 65(4):313-23. PubMed ID: 12382291
[TBL] [Abstract][Full Text] [Related]
7. Understanding microscopic binding of macrophage migration inhibitory factor with phenolic hydrazones by molecular docking, molecular dynamics simulations and free energy calculations.
Xu L; Li Y; Li L; Zhou S; Hou T
Mol Biosyst; 2012 Sep; 8(9):2260-73. PubMed ID: 22739754
[TBL] [Abstract][Full Text] [Related]
8. An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity.
El Turk F; Fauvet B; Ouertatani-Sakouhi H; Lugari A; Betzi S; Roche P; Morelli X; Lashuel HA
Bioorg Med Chem; 2010 Jul; 18(14):5425-40. PubMed ID: 20639113
[TBL] [Abstract][Full Text] [Related]
9. Free energy simulations and MM-PBSA analyses on the affinity and specificity of steroid binding to antiestradiol antibody.
Laitinen T; Kankare JA; Peräkylä M
Proteins; 2004 Apr; 55(1):34-43. PubMed ID: 14997538
[TBL] [Abstract][Full Text] [Related]
10. MIF tautomerase inhibitor potency of alpha,beta-unsaturated cyclic ketones.
Garai J; Molnár V; Eros D; Orfi L; Lóránd T
Int Immunopharmacol; 2007 Dec; 7(13):1741-6. PubMed ID: 17996684
[TBL] [Abstract][Full Text] [Related]
11. Prediction of binding for a kind of non-peptic HCV NS3 serine protease inhibitors from plants by molecular docking and MM-PBSA method.
Li X; Zhang W; Qiao X; Xu X
Bioorg Med Chem; 2007 Jan; 15(1):220-6. PubMed ID: 17064917
[TBL] [Abstract][Full Text] [Related]
12. A kinetic and stereochemical investigation of the role of lysine-32 in the phenylpyruvate tautomerase activity catalyzed by macrophage migration inhibitory factor.
Johnson WH; Czerwinski RM; Stamps SL; Whitman CP
Biochemistry; 1999 Nov; 38(48):16024-33. PubMed ID: 10625471
[TBL] [Abstract][Full Text] [Related]
13. Probing interaction requirements in PTP1B inhibitors: a comparative molecular dynamics study.
Kumar R; Shinde RN; Ajay D; Sobhia ME
J Chem Inf Model; 2010 Jun; 50(6):1147-58. PubMed ID: 20455572
[TBL] [Abstract][Full Text] [Related]
14. Molecular insight into pseudolysin inhibition using the MM-PBSA and LIE methods.
Adekoya OA; Willassen NP; Sylte I
J Struct Biol; 2006 Feb; 153(2):129-44. PubMed ID: 16376106
[TBL] [Abstract][Full Text] [Related]
15. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity.
Cheng KF; Al-Abed Y
Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations of the TEM-1 beta-lactamase complexed with cephalothin.
Díaz N; Suárez D; Merz KM; Sordo TL
J Med Chem; 2005 Feb; 48(3):780-91. PubMed ID: 15689162
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E is a MIF Inhibitor.
Hegde B; Vadnal P; Sanghavi J; Korde V; Kulkarni-Almeida AA; Dagia NM
Biochem Biophys Res Commun; 2012 Feb; 418(2):384-9. PubMed ID: 22281490
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of MIF functions in CXCR2-mediated inflammatory and atherogenic leukocyte recruitment.
Weber C; Kraemer S; Drechsler M; Lue H; Koenen RR; Kapurniotu A; Zernecke A; Bernhagen J
Proc Natl Acad Sci U S A; 2008 Oct; 105(42):16278-83. PubMed ID: 18852457
[TBL] [Abstract][Full Text] [Related]
19. An MM/3D-RISM approach for ligand binding affinities.
Genheden S; Luchko T; Gusarov S; Kovalenko A; Ryde U
J Phys Chem B; 2010 Jul; 114(25):8505-16. PubMed ID: 20524650
[TBL] [Abstract][Full Text] [Related]
20. Exploring the binding mechanisms of MIF to CXCR2 using theoretical approaches.
Xu L; Li Y; Li D; Xu P; Tian S; Sun H; Liu H; Hou T
Phys Chem Chem Phys; 2015 Feb; 17(5):3370-82. PubMed ID: 25526079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
